135 related articles for article (PubMed ID: 36812671)
21. Capillary rarefaction as an index for the microvascular assessment of hypertensive patients.
Triantafyllou A; Anyfanti P; Pyrpasopoulou A; Triantafyllou G; Aslanidis S; Douma S
Curr Hypertens Rep; 2015 May; 17(5):33. PubMed ID: 25833455
[TBL] [Abstract][Full Text] [Related]
22. Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals.
Triantafyllou A; Anyfanti P; Triantafyllou G; Zabulis X; Aslanidis S; Douma S
J Am Soc Hypertens; 2016 Aug; 10(8):640-6. PubMed ID: 27265366
[TBL] [Abstract][Full Text] [Related]
23. Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis.
Morita T; Hayashi K
Mol Cancer Res; 2018 May; 16(5):880-893. PubMed ID: 29330296
[TBL] [Abstract][Full Text] [Related]
24. Microvascular remodelling in preeclampsia: quantifying capillary rarefaction accurately and independently predicts preeclampsia.
Antonios TF; Nama V; Wang D; Manyonda IT
Am J Hypertens; 2013 Sep; 26(9):1162-9. PubMed ID: 23757401
[TBL] [Abstract][Full Text] [Related]
25. Assessment of microvascular rarefaction in human brain disorders using physiological magnetic resonance imaging.
van Dinther M; Voorter PH; Jansen JF; Jones EA; van Oostenbrugge RJ; Staals J; Backes WH
J Cereb Blood Flow Metab; 2022 May; 42(5):718-737. PubMed ID: 35078344
[TBL] [Abstract][Full Text] [Related]
26. Microvascular rarefaction in patients with cerebrovascular events.
Wadowski PP; Schörgenhofer C; Rieder T; Ertl S; Pultar J; Serles W; Sycha T; Mayer F; Koppensteiner R; Gremmel T; Jilma B
Microvasc Res; 2022 Mar; 140():104300. PubMed ID: 34953822
[TBL] [Abstract][Full Text] [Related]
27. Low birth weight infants do not have capillary rarefaction at birth: implications for early life influence on microcirculation.
D'Souza R; Raghuraman RP; Nathan P; Manyonda IT; Antonios TF
Hypertension; 2011 Nov; 58(5):847-51. PubMed ID: 21968755
[TBL] [Abstract][Full Text] [Related]
28. Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension.
Frost S; Nolde JM; Chan J; Joyson A; Gregory C; Carnagarin R; Herat LY; Matthews VB; Robinson L; Vignarajan J; Prentice D; Kanagasingam Y; Schlaich MP
Sci Rep; 2021 Jan; 11(1):1001. PubMed ID: 33441624
[TBL] [Abstract][Full Text] [Related]
29. Prediction of coronary artery disease in patients with lower extremity peripheral artery disease.
Cho SW; Kim BG; Kim DH; Kim BO; Byun YS; Rhee KJ; Lee BK; Goh CW
Int Heart J; 2015; 56(2):209-12. PubMed ID: 25740583
[TBL] [Abstract][Full Text] [Related]
30. Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity.
Querfeld U; Mak RH; Pries AR
Clin Sci (Lond); 2020 Jun; 134(12):1333-1356. PubMed ID: 32542397
[TBL] [Abstract][Full Text] [Related]
31. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
[TBL] [Abstract][Full Text] [Related]
32. Early Life Microcirculatory Plasticity and Blood Pressure Changes in Low Birth Weight Infants Born to Normotensive Mothers: A Cohort Study.
Goloba M; Raghuraman R; Botros N; Khan U; Klein M; Brown A; Duffy D; Anim-Nyame N; Wang D; Manyonda I; Antonios TF
Am J Hypertens; 2019 May; 32(6):570-578. PubMed ID: 30821323
[TBL] [Abstract][Full Text] [Related]
33. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
34. Diabetes and risk of peripheral artery disease in patients undergoing first-time coronary angiography between 2000 and 2012 - a nationwide study.
Kamil S; Sehested TSG; Carlson N; Houlind K; Lassen JF; N Bang C; Dominguez H; Pedersen CT; Gislason GH
BMC Cardiovasc Disord; 2019 Oct; 19(1):234. PubMed ID: 31651241
[TBL] [Abstract][Full Text] [Related]
35. Thymosin β4 and the vasculature: multiple roles in development, repair and protection against disease.
Dubé KN; Smart N
Expert Opin Biol Ther; 2018 Jul; 18(sup1):131-139. PubMed ID: 30063849
[TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases.
Takahara M; Iida O; Kohsaka S; Soga Y; Fujihara M; Shinke T; Amano T; Ikari Y;
Cardiovasc Diabetol; 2019 Nov; 18(1):155. PubMed ID: 31730004
[TBL] [Abstract][Full Text] [Related]
37. Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.
Heuslein JL; Li X; Murrell KP; Annex BH; Peirce SM; Price RJ
Microcirculation; 2015 Jul; 22(5):360-9. PubMed ID: 25866235
[TBL] [Abstract][Full Text] [Related]
38. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.
Padro T; Manfrini O; Bugiardini R; Canty J; Cenko E; De Luca G; Duncker DJ; Eringa EC; Koller A; Tousoulis D; Trifunovic D; Vavlukis M; de Wit C; Badimon L
Cardiovasc Res; 2020 Mar; 116(4):741-755. PubMed ID: 32034397
[TBL] [Abstract][Full Text] [Related]
39. Peripheral microcirculatory abnormalities are associated with cardiovascular risk in systemic sclerosis: a nailfold video capillaroscopy study.
Pagkopoulou E; Soulaidopoulos S; Triantafyllidou E; Arvanitaki A; Katsiki N; Loutradis C; Karagiannis A; Doumas M; Garyfallos A; Kitas GD; Dimitroulas T
Clin Rheumatol; 2021 Dec; 40(12):4957-4968. PubMed ID: 34312764
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotection by Thymosin Beta 4.
Pipes GT; Yang J
Vitam Horm; 2016; 102():209-26. PubMed ID: 27450736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
